Medical Condition News

RSS

Acorda Therapeutics receives U.S. patent allowance for aminopyridine compositions

Acorda Therapeutics, Inc. today announced that the United States Patent and Trademark Office (USPTO) has allowed U.S. Patent Application No. 11/102,559 entitled "Method of Using Sustained Release Aminopyridine Compositions."

10 Aug 2011

Nesfatin-1 protein may help reduce body weight and blood sugar

A newly-identified protein may hold the key to keeping appetite and blood sugar in check, according to a study by York University researchers.

10 Aug 2011

Scientist determines how nyctalopin gene makes night vision possible

A scientist from the Florida campus of The Scripps Research Institute has determined how a particular gene makes night vision possible. The study, which was published in the August 10, 2011 edition of The Journal of Neuroscience, focuses on a gene called nyctalopin. Mutations in the gene result in inherited "night blindness," a loss of vision in low-light environments.

10 Aug 2011

Elderly women with sleep apnea more likely to develop dementia

Elderly women who suffer from sleep apnea -- characterized by disrupted breathing and sleep and a reduction in the intake of oxygen -- are about twice as likely to develop dementia in the next five years as those without the condition, according to a multi-center study led by researchers from the University of California, San Francisco.

10 Aug 2011

New technique can help scientists rapidly map myelination

Like explorers mapping a new planet, scientists probing the brain need every type of landmark they can get. Each mountain, river or forest helps scientists find their way through the intricacies of the human brain.

10 Aug 2011

Moberg Derma receives first order for Emtrix from Walmart

The public company Moberg Derma AB has through its U.S. distributor Alterna LLC received a first order from the world's largest retail chain, Walmart, for Emtrix - its treatment of discolored and damaged nails caused by nail fungus (onychomycosis) or nail psoriasis.

10 Aug 2011

NCI, Pharmacyclics sign CRADA to develop PCI-32765 for blood cancers

Pharmacyclics, Inc. today announced the signing of a five-year Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI) to collaborate on the development of PCI-32765, a first-in-class, small molecule inhibitor of Bruton's tyrosine kinase (Btk) for the treatment of hematologic malignancies.

10 Aug 2011

IntraPace connect.abiliti Wand H102 system receives European CE Mark

IntraPace, Inc. announced today that it has received European CE Mark for the connect.abiliti Wand H102. The device provides wireless access to personal eating and exercise data to patients with an abiliti system, a unique approach to the treatment of obesity that uses gastric stimulation to help patients feel full sooner.

10 Aug 2011

Transaxillary thyroid robotic surgery removes nodules with no visible scar

As the rate of thyroid cancer continues to climb, doctors are urging patients to be more cautious about thyroid nodules, a common disorder that is responsible for a small but growing number of thyroid cancer cases.

10 Aug 2011

A diet of flaxseed shows protective effects against radiation in mice

Flax has been part of human history for well over 30,000 years, used for weaving cloth, feeding people and animals, and even making paint. Now, researchers from the Perelman School of Medicine at the University of Pennsylvania have discovered that it might have a new use for the 21st century: protecting healthy tissues and organs from the harmful effects of radiation.

10 Aug 2011

Young blacks with kidney disease more likely to die on dialysis than whites

For years, medical studies have reached the same conclusion: African-American patients do better on kidney dialysis than their white counterparts. But new Johns Hopkins research, published in the Journal of the American Medical Association, shows that younger blacks - those under the age of 50 - actually do much worse on dialysis than equally sick whites who undergo the same blood-filtering process.

10 Aug 2011

Researchers demonstrate contribution of Immunoglobulin E to atherogenesis

There is an observed correlation between Immunoglobulin E (IgE) levels atherosclerosis, with twice amount of IgE present in patients with acute myocardial infarction as in patients with stable angina or without coronary heart disease (CHD). Guo-Ping Shi, DSc, Jing Wang, MD, PhD, and colleagues in the Department of Medicine at Brigham and Women's Hospital (BWH), have demonstrated the direct participation of IgE in atherogenesis in a mouse model.

10 Aug 2011

First bioengineered anal sphincter for treatment of fecal and urinary incontinence

Researchers have built the first functional anal sphincters in the laboratory, suggesting a potential future treatment for both fecal and urinary incontinence. Made from muscle and nerve cells, the sphincters developed a blood supply and maintained function when implanted in mice.

10 Aug 2011

Novel therapy shrinks tumors without collateral damage

A potential new option is beginning to emerge for patients with the fastest growing form of cancer in the United States, according to researchers at the University of Alabama at Birmingham.

10 Aug 2011

Erythromycin can prevent and treat aseptic loosening of total joint replacement

Total joint replacement surgeries can help relieve joint pain common in people with conditions like osteoarthritis. But sometimes, the debris from prosthetic joints leads to aseptic loosening, or disintegration of surrounding bones.

10 Aug 2011

First renal denervation with Medtronic Symplicity Catheter System performed in Latin America

Medtronic today announced the first use in Latin America of renal denervation with the Medtronic Symplicity Catheter System™ to treat a patient with resistant hypertension, which is defined as high blood pressure despite treatment with three or more anti-hypertensive medications. Hypertension is an especially dangerous disease affecting hundreds of millions of people worldwide.

From Medtronic 10 Aug 2011

Hydros-TA therapy provides next generation of osteoarthritis relief

Osteoarthritis (OA) is the most common form of arthritis, affecting roughly 10% of Canadians. This degradation of the joints is painful and crippling, especially when it affects the knee. Although there are viable OA treatment options, they are short-lived and can have serious side-effects.

10 Aug 2011

UofL professor to teach and conduct research for Italian students in Fulbright Program

Learning more about how to save researchers money through decision analysis is an important area of study for Steven McCabe, MD, assistant professor, University of Louisville School of Public Health and Information Sciences. He will have the chance to exchange knowledge about decision analysis with colleagues in Italy as a Fulbright Scholar.

10 Aug 2011

Music and music therapy may benefit cancer patients

Cancer patients may benefit from sessions with trained music therapists or from listening to music. Using music can reduce anxiety in cancer patients, and may also have positive effects on mood, pain and quality of life, according to a new Cochrane systematic review led by Dr. Joke Bradt, an associate professor in Drexel University's College of Nursing and Health Professions.

10 Aug 2011

Improved patient selection and practice patterns may lower number of negative tests for CAD

Hospitals vary markedly when it comes to the rate at which diagnostic coronary angiography or catheterization - an invasive procedure that allows doctors to see the vessels and arteries leading to the heart - actually finds obstructive coronary artery disease (CAD) in people without known heart disease.

10 Aug 2011